NASDAQ$NAGE
Niagen Bioscience Inc · Q1 2025 earnings
Q1 2025 earnings ·
Briefing
Niagen Bioscience reported Q1 2025, revenue of $30.5M, net income of $5.1M, diluted EPS of $0.06.
For Q1 2025, Niagen Bioscience reported revenue of $30.5M, net income of $5.1M, diluted EPS was $0.06. The filing highlights segment performance, liquidity, and management commentary on the period.
- Revenue $30.5M.
- Net income $5.1M.
- Diluted EPS $0.06.
Headline financials
Revenue & EPS history
Niagen Bioscience Inc · Revenue · Quarterly
$30.5M
Forward guidance
Management discusses operating priorities, capital allocation, and sector risks in the quarterly filing.
Tailwinds
- Headline results and segment trends anchor the quarter.
- Liquidity and balance-sheet capacity support operations.
- Strategic initiatives outlined in MD&A.
Headwinds
- Macro, rates, or input costs may pressure margins.
- One-time items affect year-over-year comparability.
- Execution risk on growth or restructuring plans.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2025
+0.5%
Avg return
Earnings day
+2.3%
Avg return
5 days after
+2.3%
Avg return
30 days after
56%
14 / 25 earnings
Positive
+7.3%
Q2 2022
Best reaction
-6.7%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.1% | -17.4% | -28.6% | |
| Q4 2025 | +3.2% | +5.7% | -11.3% | |
| Q3 2025 | -3.9% | -5.4% | -7.3% | |
| Q1 2025 | -3.2% | +7.6% | +48.3% | |
| Q3 2024 | -2.5% | +70.7% | +115.6% | |
| Q2 2024 | -6.7% | +0.0% | +18.1% | |
| Q1 2024 | +2.1% | -9.9% | -14.7% | |
| Q3 2023 | +4.6% | -11.1% | -12.4% | |
| Q2 2023 | -0.6% | -4.2% | -7.2% | |
| Q1 2023 | +5.8% | +9.4% | +14.4% | |
| Q3 2022 | +1.8% | +31.7% | +6.7% | |
| Q2 2022 | +7.3% | -8.3% | -25.5% | |
| Q1 2022 | +0.6% | +12.3% | +29.4% | |
| Q3 2021 | +2.2% | +0.3% | -32.1% | |
| Q2 2021 | -2.1% | -2.0% | -9.2% | |
| Q1 2021 | -3.9% | -20.7% | +0.1% | |
| Q3 2020 | +1.5% | +2.1% | +3.8% | |
| Q2 2020 | -4.3% | -7.2% | -12.1% | |
| Q1 2020 | +3.9% | +5.4% | -7.6% | |
| Q3 2019 | -0.7% | +11.6% | +38.2% | |
| Q2 2019 | -2.2% | -7.6% | -9.4% | |
| Q1 2019 | +1.9% | +0.4% | -12.0% | |
| Q3 2018 | +6.0% | -1.1% | -9.2% | |
| Q2 2018 | +2.3% | +0.0% | -18.3% | |
| Q1 2018 | -2.9% | -5.2% | -1.0% | |
| Q2 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro